<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3235</item><item key="factors"><item><item key="GSE15481GSM388424"/></item><item><item key="GSE15481GSM388425"/></item><item><item key="GSE15481GSM388426"/></item><item><item key="GSE15481GSM388427"/></item><item><item key="GSE15481GSM388428"/></item><item><item key="GSE15481GSM388429"/></item><item><item key="GSE15481GSM388430"/></item><item><item key="GSE15481GSM388431"/></item><item><item key="GSE15481GSM388432"/></item><item><item key="GSE15481GSM388433"/></item><item><item key="GSE15481GSM388434"/></item><item><item key="GSE15481GSM388435"/></item><item><item key="GSE15481GSM388436"/></item><item><item key="GSE15481GSM388437"/></item><item><item key="GSE15481GSM388438"/></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Overexpression of the AP-2&#947;  transcription factor in breast tumours has been identified as an independent predictor of poor outcome and...</item><item key="pubmed_id">19798054</item><item key="geo_gse_id">E-GEOD-15481</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">15</item><item key="tags"><item>breast</item><item>breast carcinoma</item><item>carcinoma</item><item>cell</item><item>hormone</item><item>line</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">sirna-of-human-mcf-7-cells</item><item key="geo_id_plat">E-GEOD-15481_A-AFFY-44</item><item key="name">siRNA of human MCF-7 cells</item><item key="created">Sep.12, 2014</item><item key="summary">Overexpression of the AP-2&#947;  transcription factor in breast tumours has been identified as an independent predictor of poor outcome and failure of hormone therapy, even in ER positive, ErbB2 negative tumours; markers of a more favourable prognosis. To understand further the role of AP-2&#947; in breast carcinoma, we have used an RNA interference and gene expression profiling strategy using the MCF-7 cell line as a model for ER positive, ErbB2 negative tumours with AP-2&#947; overexpression. Gene expression changes between control and silenced cells implicate AP-2&#947;  in the control of cell cycle progression and developmental signalling. Experiment Overall Design: We compared the expression profiles of MCF-7 cells separately transfected with three independent AP-2&#947; targeting sequences with those from control cells treated with transfection reagent alone or a non-silencing control siRNA on Affymetrix arrays; each condition was examined in triplicate.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15481</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-15481/samples/</item></data></biogps>
